Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

592
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
592
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

856
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
856
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Neural Regulation01:37

Neural Regulation

39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Expansion microscopy of banked brain tissue.

Free neuropathology·2026
Same author

Lewy pathology largely absent in prefrontal cortices of Parkinson's disease patients undergoing deep brain stimulation.

NPJ Parkinson's disease·2026
Same author

Validity of the NINDS traumatic encephalopathy syndrome criteria for predicting chronic traumatic encephalopathy.

medRxiv : the preprint server for health sciences·2026
Same author

A new AI assisted approach aligns data standards and accelerates interoperability in biomedical research.

NPJ digital medicine·2026
Same authorSame journal

Brain extraction for fixed tissue banking: a technical report.

Free neuropathology·2026
Same author

Comorbid neuropathologies but not Braak stage influence cognitive impairment in primary age-related tauopathy.

Journal of neuropathology and experimental neurology·2026

Related Experiment Video

Updated: Jul 16, 2025

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

10.7K

Neurodegeneration: 2023 update.

John F Crary1

  • 1Department of Pathology, Nash Family Department of Neuroscience, Department of Artificial Intelligence & Human Health, Neuropathology Brain Bank & Research CoRE, Ronald M. Loeb Center for Alzheimer's Disease, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Free Neuropathology
|September 11, 2023
PubMed
Summary
This summary is machine-generated.

This review highlights key neuropathology studies, focusing on human tissue research. Advances include Alzheimer disease (AD) insights, TDP-43 mechanisms, and cryo-EM structures for neurodegenerative diseases.

Keywords:
AgingAlzheimer diseaseNeurodegenerationNeuropathologyTDP-43 proteinopathyTauopathyTraumatic brain injuryα-synucleinopathy

More Related Videos

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

17.6K
Novel Passive Clearing Methods for the Rapid Production of Optical Transparency in Whole CNS Tissue
06:14

Novel Passive Clearing Methods for the Rapid Production of Optical Transparency in Whole CNS Tissue

Published on: May 8, 2018

8.8K

Related Experiment Videos

Last Updated: Jul 16, 2025

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

10.7K
High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

17.6K
Novel Passive Clearing Methods for the Rapid Production of Optical Transparency in Whole CNS Tissue
06:14

Novel Passive Clearing Methods for the Rapid Production of Optical Transparency in Whole CNS Tissue

Published on: May 8, 2018

8.8K

Area of Science:

  • Neuroscience
  • Neuropathology
  • Genomics

Background:

  • The field of neuropathology continually advances through human tissue-based research.
  • Understanding neurodegenerative diseases requires diverse methodologies and disease category coverage.

Purpose of the Study:

  • To review ten high-impact neuropathology studies from the past year.
  • To emphasize human tissue-based research relevant to neuropathologists.
  • To cover a broad spectrum of neurodegenerative disease research.

Main Methods:

  • Integrated proteomic and transcriptomic analysis.
  • Cryogenic electron microscopy (cryo-EM) for structural determination.
  • Functional genomics and pathoanatomical studies.
  • Application of deep learning in neuropathology.

Main Results:

  • New diagnostic criteria for progressive supranuclear palsy.
  • Insights into TAR DNA-binding protein 43 (TDP-43) roles in Alzheimer disease (AD) and limbic age-related TDP-43 encephalopathy (LATE).
  • Cryo-EM revealed TMEM106B filaments in TDP-43 inclusions and prion protein amyloid structures.
  • Microglial gene expression cataloged, APOE influence on chronic traumatic encephalopathy elucidated, and Lewy body progression pathways examined.
  • Deep learning models applied to aging post-mortem brains.

Conclusions:

  • Recent neuropathology research offers significant insights into neurodegenerative disease mechanisms.
  • Advanced imaging and multi-omics approaches are revolutionizing structural and functional understanding.
  • TDP-43 and TMEM106B are critical players in specific neurodegenerative pathways.
  • Future research directions include integrating multi-omics data and deep learning for enhanced diagnostics.